McKesson Corporation (MCK) has been a topic of frequent discussion with optimistic views from investors and analysts alike. TV personality Jim Cramer considers MCK his top pick, advocating for its potential to raise prices. MCK recently completed the acquisition of
PRISM Vision Holdings, bolstering its ophthalmology portfolio. Various analyses forecasted an 11% rally for McKesson, backed by strong revenue growth. Larry Robbins, a notable investor, has turned bullish on the corporation. Over the past five years, investors have seen an impressive
451% gain in MCK. The company also reported an all-time high stock price of $726.13 amid robust growth. Additionally, Wall Street analysts consider MCK a good investment due to its long-term value. McKesson has managed to advance despite market declines and outperformed Nasdaq. Following the divestiture of Canada-based businesses Rexall and Well.ca, MCK saw a drop in its stocks. However, MCK is still considered one of the most undervalued value stocks according to analysts. The corporation beats Q4 earnings, delivering shareholders a 33% Compound Annual Growth Rate (CAGR) over 5 years. McKesson has recently raised its full-year EPS guidance following Q2 earnings beat.
Mckesson Corporation MCK News Analytics from Thu, 01 Aug 2024 07:00:00 GMT to Fri, 11 Apr 2025 12:42:25 GMT -
Rating 8
- Innovation 7
- Information 6
- Rumor -6
